JW Shinyak Corporation
JW Shinyak Corporation, a pharmaceutical company, engages in the production and sale of medicines and medical supplies in South Korea. The company offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesi… Read more
JW Shinyak Corporation (067290) - Total Assets
Latest total assets as of September 2025: ₩64.75 Billion KRW
Based on the latest financial reports, JW Shinyak Corporation (067290) holds total assets worth ₩64.75 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
JW Shinyak Corporation - Total Assets Trend (2007–2024)
This chart illustrates how JW Shinyak Corporation’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
JW Shinyak Corporation - Asset Composition Analysis
Current Asset Composition (December 2024)
JW Shinyak Corporation's total assets of ₩64.75 Billion consist of 45.4% current assets and 54.6% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩7.83 Billion | 12.4% |
| Accounts Receivable | ₩10.72 Billion | 17.0% |
| Inventory | ₩9.47 Billion | 15.0% |
| Property, Plant & Equipment | ₩19.08 Billion | 30.3% |
| Intangible Assets | ₩5.02 Billion | 8.0% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2007–2024)
This chart illustrates how JW Shinyak Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: JW Shinyak Corporation's current assets represent 45.4% of total assets in 2024, an increase from 0.0% in 2007.
- Cash Position: Cash and equivalents constituted 12.4% of total assets in 2024, up from 5.7% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, a decrease from 42.0% in 2007.
- Asset Diversification: The largest asset category is property, plant & equipment at 30.3% of total assets.
JW Shinyak Corporation Competitors by Total Assets
Key competitors of JW Shinyak Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
AGP Ltd
KAR:AGP
|
Pakistan | PKRs28.27 Billion |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
|
Korea | ₩529.96 Billion |
|
DongKoo Bio&Pharma Co. Ltd
KQ:006620
|
Korea | ₩269.00 Billion |
|
NatureCell Co.Ltd
KQ:007390
|
Korea | ₩71.32 Billion |
|
Sam-A Pharm. Co. Ltd
KQ:009300
|
Korea | ₩246.13 Billion |
|
Kyung Dong Pharmaceutical Co. Ltd
KQ:011040
|
Korea | ₩291.47 Billion |
|
WooGene B&G Co. Ltd
KQ:018620
|
Korea | ₩117.10 Billion |
|
Oscotec Inc
KQ:039200
|
Korea | ₩154.14 Billion |
JW Shinyak Corporation - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - JW Shinyak Corporation generates 1.48x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, JW Shinyak Corporation generates $8.06 in net profit.
JW Shinyak Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.27 | 1.21 | 0.87 |
| Quick Ratio | 0.81 | 0.93 | 0.48 |
| Cash Ratio | 0.00 | 0.27 | 0.00 |
| Working Capital | ₩6.38 Billion | ₩ 7.34 Billion | ₩ -5.06 Billion |
JW Shinyak Corporation - Advanced Valuation Insights
This section examines the relationship between JW Shinyak Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.11 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -3.9% |
| Total Assets | ₩63.04 Billion |
| Market Capitalization | $42.36 Million USD |
Valuation Analysis
Below Book Valuation: The market values JW Shinyak Corporation's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: JW Shinyak Corporation's assets decreased by 3.9% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for JW Shinyak Corporation (2007–2024)
The table below shows the annual total assets of JW Shinyak Corporation from 2007 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩63.04 Billion | -3.94% |
| 2023-12-31 | ₩65.62 Billion | -30.26% |
| 2022-12-31 | ₩94.09 Billion | +2.27% |
| 2021-12-31 | ₩92.00 Billion | -4.49% |
| 2020-12-31 | ₩96.33 Billion | -29.61% |
| 2019-12-31 | ₩136.85 Billion | +25.32% |
| 2018-12-31 | ₩109.21 Billion | -11.47% |
| 2017-12-31 | ₩123.36 Billion | -14.10% |
| 2016-12-31 | ₩143.61 Billion | +12.47% |
| 2015-12-31 | ₩127.68 Billion | +0.54% |
| 2014-12-31 | ₩126.99 Billion | +0.53% |
| 2013-12-31 | ₩126.32 Billion | +9.61% |
| 2012-12-31 | ₩115.25 Billion | +12.12% |
| 2011-12-31 | ₩102.79 Billion | +127.08% |
| 2008-12-31 | ₩45.27 Billion | -7.34% |
| 2007-12-31 | ₩48.85 Billion | -- |